Hillsdale Investment Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-40,000
| Closed | -$720K | – | 684 |
|
|
2020
Q3 | $720K | Buy |
40,000
+2,300
| +6% | +$41.4K | 0.07% | 260 |
|
|
2020
Q2 | $958K | Sell |
37,700
-2,000
| -5% | -$50.8K | 0.09% | 182 |
|
|
2020
Q1 | $729K | Buy |
39,700
+1,000
| +3% | +$18.4K | 0.09% | 199 |
|
|
2019
Q4 | $853K | Buy |
+38,700
| New | +$853K | 0.07% | 235 |
|
|
2019
Q1 | – | Sell |
-11,700
| Closed | -$125K | – | 714 |
|
|
2018
Q4 | $125K | Buy |
+11,700
| New | +$125K | 0.01% | 397 |
|